Cargando…
Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?
Over the past two decades, promising advancements have emerged in the field of psoriasis management. Most notably, highly effective targeted biologic therapies that offered significant breakthroughs in the management of psoriasis have been developed. One of the most challenging components of marketi...
Autores principales: | Metko, Dea, Torres, Tiago, Vender, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286538/ https://www.ncbi.nlm.nih.gov/pubmed/37309982 http://dx.doi.org/10.1177/03000605231175547 |
Ejemplares similares
-
Psoriasis, biologic therapy, and the pandemic of the 21st century
por: Nogueira, Miguel, et al.
Publicado: (2020) -
Tapinarof for the treatment of psoriasis
por: Nogueira, Sofia, et al.
Publicado: (2022) -
A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians
por: Drakos, Anastasia, et al.
Publicado: (2022) -
Systemic Role for Vitamin D in the Treatment of Psoriasis and Metabolic Syndrome
por: Fu, Lisa Wenyang, et al.
Publicado: (2011) -
A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab
por: Ghazawi, Feras M., et al.
Publicado: (2021)